Market Overview

Benzinga's Volume Movers

Related CGIX
Cancer Genetics to Report Biomarker Findings in Metastatic Clear Cell Renal Carcinoma Using a CGI-Designed NGS Panel
Cancer Genetics Receives Bankruptcy Court Approval to Purchase Los Angeles-Based Response Genetics, Inc.
Related GPN
An ETF For The Climate Conscious Investor
Armored Portfolios: The Hedged Portfolio Method

Cancer Genetics (NASDAQ: CGIX) shares moved up 6.38% to $20.85. The volume of Cancer Genetics shares traded was 1637% higher than normal. Cancer Genetics is expected to post revenue of $ 18.65 million in the year ending December, 2014.

Global Payments (NYSE: GPN) shares rose 9.25% to $55.39. The volume of Global Payments shares traded was 1130% higher than normal. Global Payments reported upbeat fiscal first-quarter results and raised its annual forecast. The company named Jeffrey S. Sloan as its new chief executive and announced its plans to buy back up to $100 million of its common stock.

Rockwell Medical (NASDAQ: RMTI) shares climbed 7.69% to $12.32. The volume of Rockwell Medical shares traded was 482% higher than normal. Rockwell Medical reported that the Phase 3 CRUISE study data has been accepted as a Late-Breaking Clinical Trial.

Allot Communications (NASDAQ: ALLT) surged 11.80% to $14.12. The volume of Allot Communications shares traded was 459% higher than normal. Allot Communications reported that it has received a new multimillion dollar order from a US-based cloud provider.

Posted-In: volume moversNews Intraday Update Markets Movers


Related Articles (ALLT + CGIX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters